insights_auto
Why is CYAD down 8.00%?
Dive Deeperchevron_right
CYAD:EBR
Celyad Oncology SA
€0.16
arrow_downward
-8.00%(-0.014) 1D
Nov 19, 5:35:23 PM GMT+1 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CYAD...
Open
€0.16
High
€0.18
Low
€0.16
Mkt. cap
7.40M
Avg. vol.
14.96K
Volume
5.05K
P/E ratio
2.15
52-wk high
€0.65
52-wk low
€0.14
EPS
€0.08
Shares outstanding
47.26M
No. of employees
5
Open
€0.16
High
€0.18
Low
€0.16
Mkt. cap
7.40M
Avg. vol.
14.96K
Volume
5.05K
P/E ratio
2.15
52-wk high
€0.65
52-wk low
€0.14
EPS
€0.08
Shares outstanding
47.26M
No. of employees
5
News stories
From web sources and news partners
ChartMill
·
1 hour ago
Most-Active S&P 500 Stocks: Ford, Super Micro, Pfizer Lead Session Volume
CNBC
·
36 minutes ago
S&P 500 heads for 6th straight decline. Plus, J&J advances two key products
TradingView
·
2 hours ago
Anthropic Jumps 27% in Record Debut, S&P 500 Eyes Sixth Straight Loss: Stock Market Today
Traders Union
·
12 minutes ago
Caleb Franzen: S&P 500 performance and AI stocks diverged under Powell and Warsh
About Celyad Oncology SA
CEOFilippo Petti
Employees5
Founded2004
HeadquartersMont-Saint-Guibert, Walloon Brabant, Belgium
SectorHealth Care
IndustryBiotechnology
Websitecelyad.com